Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
Synthetic binders developer Aptamer Group has signed a licensing agreement with Alphazyme for the use of an Optimer binder in ...
Diets, Food Health Benefits, Diseases, Therapy Share and Cite: Menkovska, M. and Raza, S. (2025) Human Gut Microbiome in ...
According to Mordor Intelligence, the blood screening market is valued at USD 3.24 billion in 2025 and is forecast to reach ...